Variable age epilepsy syndrome
MONDO:0100619An epilepsy syndrome that has an onset during variable ages and stages of life.
Also known as: variable age onset epilepsy
34 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
New epilepsy drug candidate aims to tame severe seizures
Disease control CompletedThis study tests whether cenobamate, an experimental anti-epileptic drug, can safely reduce primary generalized tonic-clonic (PGTC) seizures when added to a person's usual seizure medications. Adults and adolescents aged 12 and older with PGTC seizures are randomly assigned to re…
Phase: PHASE3 • Sponsor: SK Life Science, Inc. • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Brain device zaps seizures in Tough-to-Treat epilepsy
Disease control CompletedThis study tested a brain implant (RNS System) that delivers targeted electrical stimulation to the thalamus to reduce seizures in people aged 12 and older with drug-resistant idiopathic generalized epilepsy. The goal was to see if the device is safe and effective at cutting down…
Phase: NA • Sponsor: NeuroPace • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New drug shows promise for rare energy disorder
Disease control CompletedThis study tested a new drug called OMT-28 in 28 people with primary mitochondrial disease, a condition that affects how cells produce energy. Participants took the drug once daily for 6 months, and researchers measured safety, blood markers of inflammation, and symptoms like fat…
Phase: PHASE2 • Sponsor: Omeicos Therapeutics GmbH • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Long-Term safety of mitochondrial drug confirmed in 101 patients
Disease control CompletedThis study looked at the safety of vatiquinone in 101 people with inherited mitochondrial disease who had already taken the drug in a previous study or treatment plan. The goal was to track any side effects until the drug became commercially available or the program ended. Partic…
Phase: PHASE3 • Sponsor: PTC Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New epilepsy drug shows promise for kids in Long-Term trial
Disease control CompletedThis study looked at the long-term safety and tolerability of the drug brivaracetam in 84 children and young adults (ages 2 to 26) with childhood or juvenile absence epilepsy. Participants who had already been in a previous study were given brivaracetam and monitored for side eff…
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Oral vs. needle: which stops Kids' seizures faster?
Symptom relief CompletedThis study tested whether giving midazolam in the mouth (buccal) works as well as a shot in the thigh (intramuscular) to stop seizures in children aged 6 months to 12 years. 90 children were randomly assigned to one of the two methods. The main goal was to see if seizures stopped…
Phase: PHASE4 • Sponsor: Pakistan Air Force (PAF) Hospital Islamabad • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Could a zapping headband tame tough seizures?
Symptom relief CompletedThis study tested a device that sends a very mild electrical current to the brain (tDCS) to see if it can safely reduce seizures in people with epilepsy that doesn't respond to medication. 127 participants aged 9 and older received either real or fake (sham) stimulation for 10 se…
Phase: NA • Sponsor: Neuroelectrics Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
Traffic-light labels on menus: do they nudge us to eat better?
Knowledge-focused CompletedThis study tested whether adding Nutri-score labels (A to E ratings) to restaurant menus, alongside calorie information, helps people pick healthier meals. Over 600 adults in Liverpool ordered from a menu with either calorie info alone or calorie info plus Nutri-score labels. Res…
Phase: NA • Sponsor: University of Liverpool • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC